CN Patent

CN101212970B — Hcv蛋白酶抑制剂与表面活性剂的组合物

Assigned to Merck Sharp and Dohme LLC · Expires 2010-07-21 · 16y expired

What this patent protects

药物制剂，其含有至少一种本文的式I-XXVI的化合物和至少一种表面活性剂。该制剂中也可包括药学上可接受的载体和赋形剂。本发明的制剂适合以单一单位剂量应用。

USPTO Abstract

药物制剂，其含有至少一种本文的式I-XXVI的化合物和至少一种表面活性剂。该制剂中也可包括药学上可接受的载体和赋形剂。本发明的制剂适合以单一单位剂量应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN101212970B
Jurisdiction
CN
Classification
—
Expires
2010-07-21
Drug substance claim
No
Drug product claim
No
Assignee
Merck Sharp and Dohme LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.